{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:30Z","timestamp":1786993230863,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17pc0101019"],"award-info":[{"award-number":["JP17pc0101019"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpba.2026.117572","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:56:16Z","timestamp":1779058576000},"page":"117572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantification of PEG2000-DMG and TS-202, an ionic lipid, in rabbit plasma by LC-MS\/MS: Application to complement C5 siRNA lipid nanoparticles"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-951X","authenticated-orcid":false,"given":"Yuji","family":"Mano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117572_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jpba.2026.117572_bib2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/17425247.2024.2409142","article-title":"Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development","volume":"21","author":"Li","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jpba.2026.117572_bib3","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1073\/pnas.1306529110","article-title":"Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery","volume":"110","author":"Alabi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jpba.2026.117572_bib4","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1021\/acsnano.1c05099","article-title":"Delivery of oligonucleotide therapeutics: chemical modifications, lipid nanoparticles, and extracellular vesicles","volume":"15","author":"Bost","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpba.2026.117572_bib5","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/TP.0000000000004207","article-title":"Novel complement C5 small-interfering RNA lipid nanoparticle prolongs graft survival in a hypersensitized rat kidney transplant model","volume":"106","author":"Ishigooka","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.jpba.2026.117572_bib6","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1021\/acsomega.3c08092","article-title":"Development of the complement C5 assay by LC\u2013MS\/MS in monkey serum and comparison with enzyme-linked immunosorbent assay","volume":"9","author":"Kikuchi","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2026.117572_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jpba.2026.117572_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jpba.2026.117572_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113945","article-title":"Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection","volume":"384","author":"Ren","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2026.117572_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","article-title":"Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2026.117572_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.1553","article-title":"Pharmacokinetics of patisiran, the first approved RNA interference therapy in patients with hereditary transthyretin-mediated amyloidosis","volume":"60","author":"Zhang","year":"2020","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2026.117572_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2026.117382","article-title":"Comprehensive pharmacokinetic and tissue distribution study of \u03b1,\u03c9-dipropionic acid polyethylene glycol (PA\u2011PEG12\u2011PA) in rats using a validated UPLC\u2013MS\/MS method","volume":"272","author":"Liu","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117572_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jchromb.2019.03.003","article-title":"Analytical method for the determination of polyethylene glycol 400 as marker in porcine plasma","volume":"1113","author":"Saltzmann","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117572_bib14","unstructured":"U.S. Food and Drug Administration, Guidance for industry: bioanalytical method validation, FDA, 2018. \u3008https:\/\/www.fda.gov\/media\/70858\/download\u3009 (Accessed June 25)."},{"key":"10.1016\/j.jpba.2026.117572_bib15","unstructured":"European Medicines Agency, Guideline on bioanalytical method validation, Committee for Medicinal Products for Human Use, EMA, 2011. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf\u3009 (Accessed June 25)."},{"key":"10.1016\/j.jpba.2026.117572_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.2010.03916.x","article-title":"A practical guide for the stabilization of acyl ghrelin in human blood collections","volume":"74","author":"Blatnik","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jpba.2026.117572_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA\u2011LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jpba.2026.117572_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.omtn.2023.05.005","article-title":"Lipid nanoparticle delivery limits antisense oligonucleotide activity and cellular distribution in the brain after intracerebroventricular injection","volume":"32","author":"Byrnes","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jpba.2026.117572_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:46:47Z","timestamp":1783086407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S0731708526002402"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117572","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of PEG2000-DMG and TS-202, an ionic lipid, in rabbit plasma by LC-MS\/MS: Application to complement C5 siRNA lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117572"}}